Life Science


Camereyes has developed a simple end-to-end solution for detecting and monitoring diabetic retinopathy. The company's InSight leverages optics and deep-learning algorithms to provide a low-cost, fully automated solution in areas where professional eye care specialists may be scarce.


Check-Cap is a young and dynamic medical device company with a breakthrough solution for Colorectal Cancer Screening. The Check-Cap device requires no bowel preparation or invasive procedures, and is expected to detect clinically significant polyps within the same range of accuracy as a standard colonoscopy.

1colospan  Colospan is developing proprietary technology for colorectal surgery to prevent anastomotic leaks and divert colonic stomas. The company’s lead product is a single-use, temporary intraluminal bypass device designed to reduce contact between fecal matter and the anastomotic site. 
 dnr DNR is a worldwide pioneer in the field of Bio Imaging Systems. DNR harnesses proprietary innovative technologies, to develop a high-end line of bio-imaging products for various applications used in sophisticated research labs and diagnostic centers. 

EarlySense is bringing to market an early warning system for deteriorations of asthma, COPD, and CHF patients. Utilizing multi-disciplinary sensors, EarlySense developed proprietary, patent pending algorithms to extract a comprehensive set of vital parameters which are used to predict and identify patient deterioration in one of the above diseases.


Eximore is developing ophthalmic drug delivery products. The company’s initial target development is a non-invasive punctal plug designed to release glaucoma drugs, controlled over a long period of time. Currently compliance is only about 30% with the eye drops containing the drugs, and as such glaucoma remains the leading cause of blindness. Eximore’s product will relieve the patients from the need to apply daily eye drops and will solve the compliance problem.

1eyeyon  EyeYon Medical develops and brings to market exclusive medical ophthalmic devices, which offer relief to unmet clinical needs for millions of patients. Its innovative technologies are proven in clinical studies. EyeYon’s first product, the Hyper-CL™ therapeutic contact lens, for treating various corneal pathologies such as corneal edema, corneal erosions, entropion, bullous keratopathy and corneal dystrophies, as well as post-surgical conditions resulting from cataract extraction and corneal surgery.
 nanoretina Nano Retina, Inc. is developing an ultra-small, easy to implant, artificial retina designed to restore sight. The revolutionary solution meets an unmet clinical need with a large and growing potential market. The device will be composed of an array of independent sight cells. Each cell will contain a retina penetrating electrode for inter-retinal stimulation based on the cell’s light detection level. Wireless signals will remotely activate and control the sight-cells. Thus, Nano Retina is providing the blind with functional vision, thus enhancing the quality of their lives. 

OCON Healthcare develops, manufactures and commercialises innovative women’s health products based on IUB™, its proprietary intrauterine platform. The platform, made of a super-elastic alloy Nitinol, is an ideal carrier for hormone-free contraception and intrauterine drugs.


Omnix Medical is dedicated to the development and commercialization of highly effective antibiotic agents against resistant pathogenic bacteria strains.